India will treat a domestic Covid-19 vaccine "equally" with a prominent global one, even though the homegrown drug's efficacy has not been proven, and people will have no choice which one they get, a top government vaccine official told Reuters.
Read more about Despite controversy, govt to treat homegrown vaccine same as AstraZeneca s on Business Standard. Administering Bharat Biotech s Covaxin, a move cheered by nationalist politicians, has worried some health experts who consider it rushed
India readies for COVID-19 vaccination but vexed questions on the solution remain downtoearth.org.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from downtoearth.org.in Daily Mail and Mail on Sunday newspapers.
Govt to treat Bharat Biotech s Covaxin same as AstraZeneca s
Premium
Administering Bharat Biotech s COVAXIN, has worried some health experts who consider it rushed, as the vaccine has only limited, clinical-trial mode approval
(Photo: PTI)
Krishna N. Das,
, Reuters No vaccine is a backup to the other - both vaccines are equally important, both vaccines are hugely immunogenic, Vinod K. Paul, who heads a government panel on vaccine strategy, said. They excite immunity against the virus , he added
Share Via
Read Full Story
NEW DELHI :
India will treat a domestic COVID-19 vaccine equally with a prominent global one, even though the homegrown drug s efficacy has not been proven, and people will have no choice which they one they get, a top government vaccine official told Reuters.
India will treat a domestic COVID-19 vaccine "equally" with a prominent global one, even though the homegrown drug's efficacy has not been proven, and people will have no choice which they one they get, a top government vaccine official told Reuters.